Canopus's subsidiary Dongxing Biotechnology signed a technology development (entrustment) contract with Shanghai Jiao Tong University
I'm PortAI, I can summarize articles.
Canopus's subsidiary Dongxing Biotechnology signed a technology development contract worth 6 million yuan with Shanghai Jiao Tong University, aiming to promote the industrialization of scientific research achievements and enhance the company's core competitiveness. The contract includes the construction of optimized engineering strains for recombinant humanized collagen, the development of pilot and large-scale fermentation processes, and assistance in applying for invention patents
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments